<DOC>
	<DOCNO>NCT01602692</DOCNO>
	<brief_summary>The investigator ' main hypothesis breast reduction surgery , use tumescent solution contain dilute lidocaine epinephrine lead well control postoperative pain , nausea , vomit , short time postoperative phase care , quicker discharge hospital low number hospital readmission use tumescent solution contain dilute epinephrine .</brief_summary>
	<brief_title>A Comparison Tumescence Breast Reduction Surgery</brief_title>
	<detailed_description>Postoperative pain often undermanaged surgical patient . In outpatient surgery population , breast reduction surgery , postoperative pain lead increase narcotic use , increase nausea , surgical complication unplanned hospital admission , addition patient discomfort dissatisfaction . Tumescence method infiltrate tissue , breast , solution dilute lidocaine and/or dilute epinephrine order provide diffuse local anesthesia , hemostasis , tissue manipulation . Both type solution consider standard care University Wisconsin , Madison . There two main aim study . Aim 1 determine effect dilute lidocaine tumescent solution post-operative pain follow breast reduction surgery . Aim 2 study determine effect dilute lidocaine tumescent solution secondary post-operative outcome follow breast reduction surgery . The secondary outcome measure study include average time ( minute ) spend PACU , average time ( minute ) spend Phase 2 , total time ( minute ) end case discharge home , occurrence unplanned hospital admission , number episode post-operative nausea ( subjective feeling vs. emesis ) amount anti-emetic medication use pacu , phase 2 first 24 hour post-op . ( mg ) . The investigator hypothesize tumescence lidocaine epinephrine improve post-operative pain control lead less narcotic use first twenty four hour postoperatively . ( Aim 1 ) . The investigator also believe tumescence lidocaine epinephrine lead less time spend PACU , less time spend Phase2 , less time end case discharge home , less occurrence unplanned hospital admission , less episodes post-operative nausea less amount antiemetic medication use PACU , phase 2 first 24 hour post-op ( Aim 2 ) . The investigator propose difference could play significant role surgical outcome patient satisfaction outpatient plastic surgery .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>patient present breast reduction surgery University Wisconsin Hospital Clinics University Wisconsin Transformations Surgery Center meet exclusion criterion . Women age 18 year Breast feeding pregnant woman Incarcerated woman . Women unable give consent impaired decision make ability . Women report allergy substance use study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pain , postoperative</keyword>
	<keyword>Postoperative Nausea Vomiting</keyword>
	<keyword>Patient Readmission</keyword>
	<keyword>Time Discharge</keyword>
</DOC>